Frederik Verelst

11PUBLICATIONS
40CO-AUTHORS
Major global burdens of diseaseDisease surveillancePoverty, inclusivity and wellbeingPreventative health carePacific Peoples mothers and babies health and wellbeing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 06, 2026
Health-related Quality of Life in European Older Adults with Respiratory Syncytial Virus Over Three Respiratory Syncytial Virus Seasons.

Manel Terns Riera, Rosa Prato, Alberto Pérez-Rubio

|Mar 06, 2026
Burden of Respiratory Syncytial Virus Among Older Adults With an Acute Respiratory Infection: A Prospective Study in Six European Countries.

Manel Terns Riera, Rosa Prato, Alberto Pérez-Rubio

|Mar 12, 2025
Market and Non-Market Productivity Losses Associated with Invasive Meningococcal Disease in the USA.

Hiral Anil Shah, Ginita Jutlla, Oscar Herrera-Restrepo

|Dec 09, 2024
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States.

Elizabeth M La, Jonathan Graham, David Singer

|Mar 20, 2024
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States.

Daniel Molnar, Elizabeth M La, Frederik Verelst

|Mar 01, 2024
The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis.

Daisuke Kurai, Akiko Mizukami, Victor Preckler

Pageof 2

Frequent Collaborators

3 joint publications

Philippe Beutels

3 joint publications

Jonathan Graham

3 joint publications

Daniel Molnar

2 joint publications

Shubhangi Gawade